Orthofix Medical (OFIX) Accumulated Depreciation & Amortization (2016 - 2025)
Orthofix Medical (OFIX) has disclosed Accumulated Depreciation & Amortization for 16 consecutive years, with $77.3 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Accumulated Depreciation & Amortization rose 28.74% year-over-year to $77.3 million, compared with a TTM value of $77.3 million through Dec 2025, up 28.74%, and an annual FY2025 reading of $77.3 million, up 28.74% over the prior year.
- Accumulated Depreciation & Amortization was $77.3 million for Q4 2025 at Orthofix Medical, up from $60.1 million in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $77.3 million in Q4 2025 and bottomed at $29.0 million in Q4 2022.
- Average Accumulated Depreciation & Amortization over 5 years is $49.8 million, with a median of $53.1 million recorded in 2023.
- The sharpest move saw Accumulated Depreciation & Amortization decreased 3.1% in 2021, then skyrocketed 82.86% in 2023.
- Year by year, Accumulated Depreciation & Amortization stood at $29.6 million in 2021, then dropped by 1.96% to $29.0 million in 2022, then surged by 82.86% to $53.1 million in 2023, then rose by 13.19% to $60.1 million in 2024, then rose by 28.74% to $77.3 million in 2025.
- Business Quant data shows Accumulated Depreciation & Amortization for OFIX at $77.3 million in Q4 2025, $60.1 million in Q4 2024, and $53.1 million in Q4 2023.